Regenxbio Inc (RGNX) FY2025Q3 Earning Prediction

11/06 05:00:00

Pre-Market

Regenxbio Inc (RGNX) is set to release its earnings performance on 11/06 05:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 24.41M and an earnings per share (EPS) of -1.38 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueBEAT

24.41M

29.73M

+21.83%

EPSBEAT

-1.38

-1.20

+13.04%

AI Summary

Report

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

RGNX Transcript

REGENXBIO Inc. (RGNX) Q3 2025 Earnings Call Transcript

Positive11-6

The earnings call highlights strong financial performance with a 25% YoY revenue increase and a solid cash position. The strategic partnerships with Nippon Shinyaku and AbbVie, along with optimistic guidance, contribute positively. The Q&A session reveals confidence in regulatory pathways and manufacturing capabilities, despite some uncertainty in pricing and Medicare coverage details. Overall, the company's financial health, strategic partnerships, and optimistic guidance suggest a positive stock price reaction.

REGENXBIO Inc. (RGNX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Neutral9-8

REGENXBIO Inc. (RGNX) Q2 2025 Earnings Call Transcript

Positive8-8

The earnings call summary highlights strategic partnerships, promising drug developments, and a solid cash position. The Q&A section reveals proactive strategies for market positioning and safety assurances, with management addressing concerns confidently. Despite some unclear cost details, the overall sentiment is positive due to expected FDA approvals, promising clinical data, and strategic market plans. Adjustments for partnerships and potential milestone payments further boost sentiment.

REGENXBIO Inc. (RGNX) Q1 2025 Earnings Call Transcript

Unknown5-13

The earnings call presents a mixed outlook. Positive factors include strategic partnerships, a strong cash position, and reduced R&D expenses. However, regulatory risks, competitive pressures, and uncertainties in the FDA approval process pose challenges. The Q&A session reveals cautious optimism but also highlights management's avoidance of direct answers on certain regulatory aspects. The stock price is likely to remain stable in the short term, as the market awaits further clarity on FDA approvals and product launches.

RGNX Report

Frequently Asked Questions

What is the Regenxbio Inc FY2025Q3 Earnings Release Date and Time?

Regenxbio Inc (RGNX) is scheduled to release its FY2025Q3 earnings report onNov 6, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Regenxbio Inc FY2025Q3 Revenue and EPS?

Analysts' consensus predicts 24.41M in revenue and an EPS of -1.38 for Regenxbio Inc's FY2025Q3.

What Does Intellectia's AI Predict for Regenxbio Inc FY2025Q3 Earnings?

Intellectia's exclusive AI algorithms forecast a forRegenxbio Inc's FY2025Q3 earnings, with a prediction date of Nov 6, 2025. Regenxbio Inc

How Can I Use This Earnings Prediction to Trade RGNX Stock?

Leverage Intellectia's AI forecast to position trades ahead of theNov 6, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Regenxbio Inc FY2025Q3?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!